Introduction: Stem cell-based regenerative medicine has provided an excellent opportunity
to investigate therapeutic strategies and innovative treatments for Alzheimer's disease (AD) …

Stem cell therapy is a promising and rapidly advancing treatment strategy for a multitude of
neurologic disorders. Yet, while early phase clinical trials are being pursued in many …

Stem-cell-based therapy is very promising for Alzheimer's disease (AD), yet has not become
a reality. A critical challenge is the transplantation microenvironment, which impacts the …

Abstract Alzheimer's disease (AD), a progressive dementia, is one of the world's most
dangerous and debilitating diseases. Clinical trial results of amyloid-β (Aβ) and tau …

Mesenchymal stem cells (MSCs) are self-renewing cells found in almost all postnatal organs
and tissues in the perivascular region. These cells have a high capacity for mesodermal …

Alzheimer's disease (AD) is the most common neurodegenerative disease, characterized by
progressive memory loss and cognitive impairment due to excessive accumulation of …

Stem cell-based therapies (SCT) to treat neurodegenerative disorders have promise but
clinical trials have only recently begun, and results are not expected for several years. While …

Numerous modalities exist through which the central nervous system (CNS) may sustain
injury or impairment, encompassing traumatic incidents, stroke occurrences, and …

An increasing number of research on stem cells and Alzheimer's disease (AD) has been
accomplished, making stem cells the research hotspot in the field. This study was conducted …

Alzheimer's Disease (AD) is characterized primarily by the buildup of beta-amyloid plaques
and tau proteins. It is a very common neurodegenerative disease that is marked by cognitive …